Insights On Partnering
-
Achieving Excellence In IO Clinical Trials
6/21/2023
Immuno-oncology therapies have revolutionized the treatment of cancer patients worldwide. Learn how to plan for success and reduce risk when developing novel treatments for patients with cancer.
-
Weighing FSP Model Suitability For Clinical Trials
3/27/2023
Consider several key points outlined in this article when deciding if a functional service approach could better serve a clinical team and its drug development study.
-
3 Steps To Improve Site Acceptance Of ePRO In Medical Device Trials
3/6/2023
Discover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.
-
The Advantages Of Outsourcing IRB And IBC Reviews To One Partner
8/30/2023
To streamline reviews, learn how sponsors can coordinate both IBC and IRB assessments through a vendor offering integrated resources.
-
Pursuing Breakthrough Therapies For Rare Metabolic Diseases
2/14/2024
Discover how Veristat’s full-service clinical trial team helped tightly coordinate a gene therapy's dosing administration and data review.
-
Expedite Study Startup: Four Strategies To Optimize Site Activation
4/11/2022
This white paper will explore four strategies to execute across site selection, training, ethics review, and site initiation.
-
A Different Kind Of CRO
1/30/2023
Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.
-
Practical Applications Of ICH E6(R3): What Do We Need To DO?
12/14/2023
Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.
-
A Site's Point Of View Into Study Start-Up
12/8/2023
Learn how sites can enhance their ability to meet start-up timelines, positively impacting both operational efficiency and patient outcomes.
-
Potential Fraud And Misconduct Investigated At Clinical Research Sites
9/26/2023
Uncover the truth of a for-cause investigation of potential misconduct and/or fraudulent activity on the part of senior management and investigators at one or more sites within a research organization.